About aiGENE

aiGENE is a universal blood test that measures cancer and cancer therapy efficacy.

Company Highlights
Year Founded

2019

icon-altEmployees

4

Location (HQ)

USA

Since Last Funding

1 year 3 months

Monthly Website Visitors

2.1K

icon-altTotal Investment Amt

$300K

Last Funding Round

Grant

icon-altMoM Headcount Growth

32.26%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Health Care

Biotechnology Research